Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction
Explore this paper's citation graph
Summary
In symptomatic patients without overt CAD, impaired CFR was independently associated with diastolic dysfunction and adverse events, especially HFpEF hospitalization, and the presence of both coronary microvascular and diastsolic dysfunctions was associated with a markedly increased risk ofHFpEF events.
- Type
- book
- Published
- 2018-03-07
- Cited by
- 514
- References
- 36
- Access
- Open access
- OpenAlex
- https://openalex.org/W29293969
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:4821618
Keywords
Business
References
- ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures
- A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.
- Global Coronary Flow Reserve Is Associated With Adverse Cardiovascular Events Independently of Luminal Angiographic Severity and Modifies the Effect of Early Revascularization
- Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease.
- Heart failure with preserved ejection fraction
- Interaction of Impaired Coronary Flow Reserve and Cardiomyocyte Injury on Adverse Cardiovascular Outcomes in Patients Without Overt Coronary Artery Disease
- Coronary Microvascular Rarefaction and Myocardial Fibrosis in Heart Failure with Preserved Ejection Fraction
- Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia.
- Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events.
- Cardiac Magnetic Resonance Postcontrast T1 Time Is Associated With Outcome in Patients With Heart Failure and Preserved Ejection Fraction
- Reproducibility and Accuracy of Quantitative Myocardial Blood Flow Using 82Rb-PET: Comparison with 13N-Ammonia
- How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.
- Patient Selection in Heart Failure With Preserved Ejection Fraction Clinical Trials
- Anatomic versus physiologic assessment of coronary artery disease. Role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making.
- Prognostic value of cardiac troponin I measured with a highly sensitive assay in patients with stable coronary artery disease.
- Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes.
- Improved Cardiac Risk Assessment with Non-Invasive measures of Coronary flow reserve
- Inflammation, Coronary Flow Reserve, and Microvascular Dysfunction
- Impairment of Coronary Flow Reserve Evaluated by Phase Contrast Cine‐Magnetic Resonance Imaging in Patients With Heart Failure With Preserved Ejection Fraction
- Extracellular Volume Fraction for Characterization of Patients With Heart Failure and Preserved Ejection Fraction.
Cited by
- Adipose-derived cells improve left ventricular diastolic function and increase microvascular perfusion in advanced age
- Coronary microvascular dysfunction and heart failure with preserved ejection fraction as female-pattern cardiovascular disease: the chicken or the egg?
- Novel insights in HFpEF, cardiomyopathies, and myocarditis.
- Heart failure with preserved ejection fraction: A systemic disease linked to multiple comorbidities, targeting new therapeutic options.
- The right ventricle in heart failure with preserved ejection fraction
- Sex Differences in the Coronary System
- Heart failure with preserved ejection fraction: unravelling an enigma.
- Coronary Microvascular Dysfunction and Cardiovascular Risk in Obese Patients
- Treating heart failure with preserved ejection fraction: learning from pulmonary fibrosis
- Striving to improve 82Rubidium PET MPI accuracy
- Microvascular Dysfunction and Hyperglycemia: A Vicious Cycle With Widespread Consequences
- Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
- Why do we care about coronary microvascular dysfunction and heart failure with preserved ejection fraction: addressing knowledge gaps for evidence-based guidelines
- A Lack of Reserve
- The new clinical standard of integrated quadruple stress echocardiography with ABCD protocol
- Sex differences in calcified plaque and long-term cardiovascular mortality: observations from the CAC Consortium
- Imaging and Management of Heart Failure and Preserved Ejection Fraction
- Late sodium channel blockade improves angina and myocardial perfusion in patients with severe coronary microvascular dysfunction: Women’s Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction ancillary study
- Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris
- Long-term prognostic value of quantitative myocardial perfusion in patients with chest pain and normal coronary arteries